Market Cap 185.26M
Revenue (ttm) 134.86M
Net Income (ttm) 2.35M
EPS (ttm) N/A
PE Ratio 34.77
Forward PE 31.72
Profit Margin 1.74%
Debt to Equity Ratio 0.38
Volume 45,500
Avg Vol 150,426
Day's Range N/A - N/A
Shares Out 20.34M
Stochastic %K 28%
Beta 1.71
Analysts Strong Sell
Price Target $14.20

Company Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 248 291 1210
Fax: 800 455 4338
Address:
3851 West Hamlin Road, Rochester Hills, United States
SuperGreenToday
SuperGreenToday Dec. 19 at 5:33 PM
$INFU Share Price: $9.28 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $0.79 – $0.97 Target Zone: $1.45 – $1.77 Potential Upside: 74% ROI Time to Expiration: 146 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockBraker
StockBraker Dec. 17 at 1:25 PM
$INFU From 12/11
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 12:29 AM
$INFU eyes on tape, stay tuned...
0 · Reply
StudBull
StudBull Dec. 10 at 10:58 PM
$INFU https://www.businesswire.com/news/home/20251210870751/en/Ambulatory-Infusion-Pumps-used-in-Pain-Management-Business-by-InfuSystem-to-Receive-Separate-Payment-Under-NOPAIN-Act-Starting-January-1-2026
0 · Reply
JohnTrack
JohnTrack Dec. 10 at 10:31 PM
$INFU fresh mention!! https://www.rapidticker.com/news/infu-sec-filing-db6df1
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 22 at 9:11 PM
0 · Reply
StudBull
StudBull Nov. 18 at 2:26 PM
$INFU Should be viewed as a more defensive name. Just sayin’
0 · Reply
W15E
W15E Nov. 8 at 5:02 AM
$INFU 🧐
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 5:56 PM
Roth Capital has adjusted their stance on InfuSystems Holdings ( $INFU ), setting the rating to Buy with a target price of 13 → 14.
0 · Reply
StockBraker
StockBraker Nov. 4 at 1:43 PM
$INFU InfuSystem Reports Third Quarter 2025 Financial Results ** Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year ** Net income of $2.3 million, up 25% ** Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% ** Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% ** Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% ** Stock Repurchases totaled $2.2 million during third quarter ** Reaffirms Full-Year 2025 Guidance
1 · Reply
Latest News on INFU
InfuSystem Set To Be A Cash Cow In 2026

Nov 10, 2025, 12:02 PM EST - 6 weeks ago

InfuSystem Set To Be A Cash Cow In 2026


InfuSystem Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 6:30 AM EST - 7 weeks ago

InfuSystem Reports Third Quarter 2025 Financial Results


5 Best Stocks For Mild Stagflation

Oct 28, 2025, 8:00 AM EDT - 2 months ago

5 Best Stocks For Mild Stagflation

BTG EWZ


InfuSystem: A New Sheriff In Town

Aug 26, 2025, 8:38 AM EDT - 4 months ago

InfuSystem: A New Sheriff In Town


InfuSystem Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 6:30 AM EDT - 5 months ago

InfuSystem Reports Second Quarter 2025 Financial Results


InfuSystem: Investments Are Starting To Pay Off

Jun 22, 2025, 1:30 AM EDT - 6 months ago

InfuSystem: Investments Are Starting To Pay Off


InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript

May 10, 2025, 12:06 PM EDT - 8 months ago

InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call Transcript


InfuSystem Reports First Quarter 2025 Financial Results

May 8, 2025, 6:30 AM EDT - 8 months ago

InfuSystem Reports First Quarter 2025 Financial Results


InfuSystem Set For Strong Year

Feb 10, 2025, 9:21 AM EST - 11 months ago

InfuSystem Set For Strong Year


InfuSystem Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 6:30 AM EST - 1 year ago

InfuSystem Reports Third Quarter 2024 Financial Results


InfuSystem Set For Strong Second Half

Aug 26, 2024, 9:03 AM EDT - 1 year ago

InfuSystem Set For Strong Second Half


InfuSystem Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 6:30 AM EDT - 1 year ago

InfuSystem Reports Second Quarter 2024 Financial Results


InfuSystem Announces $20 Million Stock Repurchase Program

May 20, 2024, 4:30 PM EDT - 1 year ago

InfuSystem Announces $20 Million Stock Repurchase Program


InfuSystem Reports First Quarter 2024 Financial Results

May 9, 2024, 6:30 AM EDT - 1 year ago

InfuSystem Reports First Quarter 2024 Financial Results


InfuSystem Holdings: 2024 Will Be A Year Of Monetization

Feb 28, 2024, 11:48 PM EST - 1 year ago

InfuSystem Holdings: 2024 Will Be A Year Of Monetization


InfuSystem Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 6:30 AM EST - 2 years ago

InfuSystem Reports Third Quarter 2023 Financial Results


SuperGreenToday
SuperGreenToday Dec. 19 at 5:33 PM
$INFU Share Price: $9.28 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $0.79 – $0.97 Target Zone: $1.45 – $1.77 Potential Upside: 74% ROI Time to Expiration: 146 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StockBraker
StockBraker Dec. 17 at 1:25 PM
$INFU From 12/11
0 · Reply
JohnTrack
JohnTrack Dec. 11 at 12:29 AM
$INFU eyes on tape, stay tuned...
0 · Reply
StudBull
StudBull Dec. 10 at 10:58 PM
$INFU https://www.businesswire.com/news/home/20251210870751/en/Ambulatory-Infusion-Pumps-used-in-Pain-Management-Business-by-InfuSystem-to-Receive-Separate-Payment-Under-NOPAIN-Act-Starting-January-1-2026
0 · Reply
JohnTrack
JohnTrack Dec. 10 at 10:31 PM
$INFU fresh mention!! https://www.rapidticker.com/news/infu-sec-filing-db6df1
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 22 at 9:11 PM
0 · Reply
StudBull
StudBull Nov. 18 at 2:26 PM
$INFU Should be viewed as a more defensive name. Just sayin’
0 · Reply
W15E
W15E Nov. 8 at 5:02 AM
$INFU 🧐
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 5:56 PM
Roth Capital has adjusted their stance on InfuSystems Holdings ( $INFU ), setting the rating to Buy with a target price of 13 → 14.
0 · Reply
StockBraker
StockBraker Nov. 4 at 1:43 PM
$INFU InfuSystem Reports Third Quarter 2025 Financial Results ** Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year ** Net income of $2.3 million, up 25% ** Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% ** Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% ** Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% ** Stock Repurchases totaled $2.2 million during third quarter ** Reaffirms Full-Year 2025 Guidance
1 · Reply
OldManGrumble
OldManGrumble Nov. 3 at 7:53 PM
$INFU Worth noting
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 5:44 PM
$INFU surges 75.2% in 3 months — what's fueling the rally? 🚀 🔥 Strong Patient Services & Device Solutions performance 📈 Higher treatment volume and increased third-party payer collections in Oncology and Wound Care boost revenues 🔧 Strategic restructuring with GE Healthcare underway Discover why $INFU is outperforming its peers like $PAHC, $PODD, and $LMAT 👉 https://www.zacks.com/stock/news/2783746/can-strength-in-rental-business-drive-infu-stock-before-q3-earnings?cid=sm-stocktwits-2-2783746-body-19156&ADID=SYND_STOCKTWITS_TWEET_2_2783746_BODY_19156
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 4:44 PM
$INFU gearing up for Q3 earnings with momentum from its rental business 📈 Stronger rental contracts and new ERP upgrades are set to lift margins across both Patient Services and Device Solutions segments. See what could fuel the next leg higher 👉 https://www.zacks.com/stock/news/2783746/can-strength-in-rental-business-drive-infu-stock-before-q3-earnings?cid=sm-stocktwits-2-2783746-teaser-19145&ADID=SYND_STOCKTWITS_TWEET_2_2783746_TEASER_19145
0 · Reply
StudBull
StudBull Oct. 17 at 1:29 PM
$INFU Roth boosts their $INFU price target from $12 to $13 after management-investor meetings at the Roth Healthcare Opportunities Conference last Thurs
0 · Reply
StudBull
StudBull Oct. 16 at 2:57 PM
1 · Reply
StudBull
StudBull Oct. 8 at 3:27 PM
$INFU management will be meeting with investors at the Roth Healthcare Opportunities Conference tomorrow. Why sell in front of those meetings?
0 · Reply
ladderGoblin
ladderGoblin Oct. 5 at 7:48 AM
$INFU Medical device niche. Testing key support. Volume pattern shows distribution. Avoid until momentum shifts.
0 · Reply
StudBull
StudBull Sep. 29 at 8:29 PM
$INFU https://www.businesswire.com/news/home/20250925724240/en/InfuSystem-to-Present-at-4th-Annual-ROTH-Healthcare-Opportunities-Conference-on-October-9-2025
0 · Reply
StudBull
StudBull Sep. 23 at 6:38 PM
$INFU New analyst assumes coverage at Lake Street and boosts price target from $12.5 to $15
0 · Reply
ZacksResearch
ZacksResearch Sep. 15 at 10:50 AM
UPDATED: Best Stocks to Buy Now $TSNDF $NEXN $MRX $OPPT $INFU https://www.zacks.com/featured-articles/101/best-stocks-to-buy-now
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 12:09 PM
$INFU Really good write-up that perfectly summarizes INFU's present situation. So if you want to bring your INFU knowledge up to date or just discover INFU, this is required reading. https://beyondspx.com/quote/INFU/analysis/infusystem-unlocking-profitable-growth-through-strategic-diversification-and-operational-acuity-nyse-infu
0 · Reply
StudBull
StudBull Sep. 8 at 2:01 PM
$INFU Seems clear to me
0 · Reply